Authors: DIAVCITRIN O ATANACKOVIC G KOREN G

Citation: O. Diavcitrin et al., CORRELATION BETWEEN INITIAL HEPATIC IRON CONCENTRATION AND RESPONSE TO DEFERIPRONE (L1) IN PATIENTS WITH BETA-THALASSEMIA MAJOR, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 77-77

Authors: LOEBSTEIN R DIAVCITRIN O ATANACKOVIC G OLIVIERI NF KOREN G

Citation: R. Loebstein et al., DEFERIPRONE-INDUCED AGRANULOCYTOSIS - A CRITICAL-REVIEW OF 5 RECHALLENGED CASES, Clinical drug investigation, 13(6), 1997, pp. 345-349

Authors: LOEBSTEIN R ZAHID N DIAVCITRIN O ATANACKOVIC G UETRECHT J KOREN G

Citation: R. Loebstein et al., DEFERIPRONE(L1)-INDUCED AGRANULOCYTOSIS - A POSSIBLE MECHANISM, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 9-9

Authors: DIAVCITRIN O ATANACKOVIC G LOEBSTEIN R KOREN G

Citation: O. Diavcitrin et al., INVESTIGATION OF VARIABILITY IN RESPONSE TO DEFERIPRONE(L1) IN PATIENTS WITH BETA-THALASSEMIA MAJOR, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 38-38

Authors: DIAYCITRIN O ATANACKOVIC G OLIVIERI NF KOREN G

Citation: O. Diaycitrin et al., PHARMACOKINETIC(PK) DYNAMIC EVALUATION OF DECREASED LONG-TERM EFFECTIVENESS OF DEFERIPRONE (L(1)), Clinical pharmacology and therapeutics, 59(2), 1996, pp. 83-83